The importance of CCT2 in breast cancer was further examined with patient data from The Cancer Genome Atlas (TCGA), showing that only genomic alterations in CCT2 resulted in statistically significant differences in patient survival (Fig. 1B,C). The gene discussed is CCT2; the disease is breast cancer.